Drug Amyotrophic Lateral Sclerosis

Radicava Ors

Payments companies reported to CMS as associated with Radicava Ors. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$282Kassociated payments (2023-2025)
2,478clinicians with associated payments
3companies reporting

By year

2023 $82K
2024 $146K
2025 $54K

Payments reported as associated with Radicava Ors, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurology (Psychiatry & Neurology) $143K
Internal Medicine $50K
Clinical Neurophysiology $16K
Neuromuscular Medicine (Psychiatry & Neurology) $16K
Family $12K
Physician Assistant $7,271

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Radicava Ors

These are the largest totals companies reported as associated with Radicava Ors. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Benjamin Brooks Charlotte, NC Internal Medicine $48,012.57
Gary Pattee Lincoln, NE Neurology (Psychiatry & Neurology) $16,776.24
John Novak Westerville, OH Clinical Neurophysiology $13,528.92
Michael Elliott Seattle, WA Neurology (Psychiatry & Neurology) $12,121.77
Erik Pioro Chicago, IL Neuromuscular Medicine (Psychiatry & Neurology) $11,820.53
Martina Wiedau Los Angeles, CA Neurology (Psychiatry & Neurology) $11,811.42
Terry Heiman-Patterson Philadelphia, PA Neurology (Psychiatry & Neurology) $10,992.18
Chelsea Shugars Chattanooga, TN Neurology (Psychiatry & Neurology) $7,639.84
Eufrosina Young Hamilton, NY Neurology (Psychiatry & Neurology) $7,248.18
Jonathan Katz San Francisco, CA Neurology (Psychiatry & Neurology) $6,213.73

Prescribed Radicava Ors?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.